The purpose of this study is to understand whether immune responses to herpes simplex virus type 2 bring HIV infected cells to the genital tract in people with HIV infection. The study will last for 5 months and involve 8 clinic visits.
Category: Research Studies
Novavax COVID-19 Vaccine Trial
This is a clinical trial of a Phase 3 vaccine for the prevention of COVID-19. Our research site is testing the SARS-CoV-2 recombinant spike protein nanoparticle vaccine that is now being developed as part of Operation Warp Speed by a new NIH network – the Coronavirus Prevention Network, or CoVPN – and Novavax as the pharmaceutical partner.